Prevalence of Undiagnosed Depression in Patients With Type 2 Diabetes
Dina Siddiq Abdulhadi Alajmani,Amna Mohamad Alkaabi,Mariam Waleed Alhosani,Ayesha Abdulaziz Folad,Fawzia Ahmed Abdouli,Frederick Robert Carrick,Mahera Abdulrahman
DOI: https://doi.org/10.3389/fendo.2019.00259
IF: 6.055
2019-05-03
Frontiers in Endocrinology
Abstract:<h1>Prevalence of Undiagnosed Depression in Patients With Type 2 Diabetes</h1><a href="http://www.frontiersin.org/people/u/664115">Dina Siddiq Abdulhadi Alajmani</a><sup>1</sup>, Amna Mohamad Alkaabi<sup>1</sup>, Mariam Waleed Alhosani<sup>1</sup>, Ayesha Abdulaziz Folad<sup>1</sup>, Fawzia Ahmed Abdouli<sup>1</sup>, <a href="http://www.frontiersin.org/people/u/96141">Frederick Robert Carrick</a><sup>2,3,4</sup> and <a href="http://www.frontiersin.org/people/u/455520">Mahera Abdulrahman</a><sup>1</sup><sup>*</sup><ul><li><span><sup>1</sup></span>Dubai Health Authority, Dubai, United Arab Emirates</li><li><span><sup>2</sup></span>Department of Neurology, Carrick Institute, Cape Canaveral, FL, United States</li><li><span><sup>3</sup></span>Department of Neurology, University of Central Florida College of Medicine, Orlando, FL, United States</li><li><span><sup>4</sup></span>Centre for Mental Health Research in Association, University of Cambridge, Cambridge, United Kingdom</li></ul><p><strong>Introduction:</strong> Type 2 Diabetes Mellitus (T2DM) is the most prevalent type of diabetes among adults and constitutes around 90% of all cases. Substantial evidence demonstrates that depression in the context of diabetes is associated with a wide range of adverse consequences such as reduced adherence to the prescribed treatment regimen, lower quality of life, higher fasting glucose and HbA1c levels, and higher health expenditures.</p><p><strong>Results:</strong> Out of 1,050 diabetic patients approached, 559 were within our inclusion criteria and agreed to participate in this study (Response rate of 53%). The mainstream of the participants had T2DM for <10 years (393, 70%), were under oral hypoglycemic treatment only (479, 86%), and had good medication adherence (526, 94%). The overall depression prevalence using a cutoff of 16 was 17%. When we assessed the level of depression amongst participants in association with their sociodemographic and clinical characteristics, there was a significant difference between age groups (<i>p</i> < 0.00001); gender (<i>p</i> < 0.0001); nationality (<i>p</i> < 0.00001); educational level (<i>p</i> < 0.00001); and employment status (<i>p</i> < 0.0001). The type of clinic in which the T2DM patients were attending (e.g., diabetes mini-clinic vs. General Family Clinic) was also significantly associated with depression (<i>p</i> < 0.0001).</p><p><strong>Conclusion:</strong> Our results demonstrate that the intensive service being given in a diabetes mini-clinic compared to routine PHC clinics appears to benefit the psychological aspects of T2DM patients in the UAE population resulting in a lower incidence of depression than commonly seen in a diabetic population. We have identified a need for the establishment of these mini-clinics in each PHC clinics; and the development of campaigns and educational programs, both for health care providers and the public to decrease depression in T2DM patients in this region.</p><h2>Introduction</h2><p>There are differences and similarities between the diabetes-specialty clinics with respect to diabetes management and outcome underscoring the necessity for a protocol-driven treatment approach in ensuring improved diabetes care and outcome (<a href="#B1">1</a>). We have developed diabetes-specialty clinics in UAE and desired to investigate and differences in outcomes of diabetes treatment in these clinics and in the general medical clinic.</p><p>Diabetes mellitus (DM) is a chronic, multifaceted, and progressive disease. Global estimates demonstrate an increase in the prevalence of DM from 422 million patients in 2016 to 642 million by the year 2040 (<a href="#B2">2</a>). Type 2 DM (T2DM) is the most prevalent type of diabetes among adults and constitutes around 90% of all cases (<a href="#B2">2</a>–<a href="#B4">4</a>). Remarkably, 70% of these individuals live in developing countries (<a href="#B5">5</a>, <a href="#B6">6</a>). According to the International Diabetes Federation (IDF), more than 35.4 million of people in the Middle East and North Africa region have diabetes and it is predicted that the number will rise to 72.1 million by 2040 (<a href="#B2">2</a>).</p><p>The UAE is a newly developing country with massive changes in lifestyle and eating habits occurring over the last 47 years. After the discovery of oil in this region in the 1970s, urbanization and growth in prosperity brought major lifestyle changes to the native population. A survey from the United Arab Emirates (UAE) in 2009, found a diabetes prevalence of 23% (<a href="#B7">7</a>), placing UAE among the countries in the world with the highest diabetes prevalence (<a href="#B2">2</a>). According to IDF, the prevalence of DM in UAE was 15.6% in the year 2017, and it might reach to 23.4% by 2045; furthermore, there were over 1 million cases of diabetes in UAE in 2017 (<a href="#B2">2</a>).</p><p>Depressi<p>-Abstract Truncated-</p>
endocrinology & metabolism